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Primary care
Re-engineering systems for the treatment of depression in primary
care: cluster randomised controlled trial
Allen J Dietrich, Thomas E Oxman, John W Williams Jr, Herbert C Schulberg, Martha L Bruce, Pamela W Lee, Sheila
Barry, Patrick J Raue, Jean J Lefever, Moonseong Heo, Kathryn Rost, Kurt Kroenke, Martha Gerrity, Paul A Nutting
Abstract
Objective To test the effectiveness of an evidence based model
for management of depression in primary care with support
from quality improvement resources.
Design Cluster randomised controlled trial.
Setting Five healthcare organisations in the United States and
60 affiliated practices.
Patients 405 patients, aged ≥ 18 years, starting or changing
treatment for depression.
Intervention Care provided by clinicians, with staff providing
telephone support under supervision from a psychiatrist.
Main outcome measures Severity of depression at three and
six months (Hopkins symptom checklist-20): response to
treatment ( ≥ 50% decrease in scores) and remission (score of
< 0.5).
Results At six months, 60% (106 of 177) of patients in
intervention practices had responded to treatment compared
with 47% (68 of 146) of patients in usual care practices
(P = 0.02). At six months, 37% of intervention patients showed
remission compared with 27% for usual care patients
(P = 0.014). 90% of intervention patients rated their depression
care as good or excellent at six months compared with 75% of
usual care patients (P = 0.0003).
Conclusion Resources such as quality improvement
programmes can be used effectively in primary care to
implement evidence based management of depression and
improve outcomes for patients with depression.
Introduction
Depression is frequently treated in primary care,1 yet there are
barriers to its effective management.2 3 Recent randomised con-
trolled trials in primary care showed benefits for patients with
depression from increased telephone support, better coopera-
tion between primary care and mental health professionals, and
more systematic follow up.4–6 Some of these changes are costly,
however, and their implementation has required intensive
support from research teams. Changes have also proved difficult
to sustain outside externally funded research.7
To disseminate these models widely, strategies are needed to
support their implementation and maintenance in community
settings. To be practical, these strategies should be based on
available resources. Our project, the re-engineering systems for
primary care treatment of depression, relied on established qual-
ity improvement programmes. In the United States these
programmes are typically part of the infrastructure of large
medical groups. Their charge includes the collection of data on
performance quality, the provision of these data to clinicians and
administrators, and assistance for clinicians and practices to
meet targets through educational support, additional resources,
and changes in practice organisation. Similar resources could be
developed through national health programmes and profes-
sional organisations.8 9
We developed and tested a model of evidence based
management of depression that could be widely disseminated.
We hypothesised that implementation would improve targeted
processes for management of depression and improve outcomes
at six months.
Methods
We recruited five healthcare organisations (three medical groups
and two health plans) across the United States. To be eligible,
each needed to be affiliated with at least 10 primary care
practices, have an established quality improvement programme,
and be willing to sustain and disseminate our model if it added
value at reasonable cost. Methods are described in detail
elsewhere.10
Leaders of the five organisations invited the affiliated
practices to participate. Sixty practices were identified. An evalu-
ation centre randomised these practices after stratification by
healthcare organisation. The practices were paired on the basis
of clinicians’ specialty (internal medicine or family practice),
number of clinicians, onsite mental health care (yes or no), and
distance from the organisation’s central office. Within pairs,
practices were randomly assigned to intervention or usual care
by flip of a coin.
Participant flow and follow up
Between February 2002 and February 2003 the clinicians identi-
fied patients aged 18 years or older who were starting or chang-
ing treatment for depression. Participants had to have a
telephone, speak English, and meet the criteria of the Diagnostic
and Statistical Manual of Mental Disorders fourth edition for major
depressive disorder and dysthymia. The evaluation centre deter-
mined diagnoses using a structured interview.11 The severity of
depression was assessed with the Hopkins symptom checklist-20,
with a score of 0.5 or more required for enrolment.12
Patients were excluded if they were unobtainable for an
evaluation interview within 14 days of their index primary care
visit, were pregnant, or had suicidal thoughts, schizophrenia,
bipolar disorder, post-traumatic stress disorder, or a substance
misuse disorder. Figure 1 shows the flow of patients through the
trial.
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Intervention
The intervention concerned a systematic approach to the assess-
ment and management of depression by the clinician, with a
centrally based care manager providing telephone support for
patients.13 Most of the care managers had backgrounds in
primary care or mental health nursing. The patient health
questionnaire-9 was used to aid in diagnosis, to monitor
treatment response, and to guide changes in treatment.11 14 15
Patients received a follow up telephone call from the care
manager one week after their initial visit. Thereafter they were
telephoned monthly and as needed until remission. The care
managers assisted patients in overcoming barriers to adherence
to the protocol. They supported self management practices such
as exercise or engaging in social activities. At the monthly calls
the questionnaire was re-administered. The clinician was
provided with the reports, including the score from the
questionnaire.
Psychiatrists employed by the organisations supervised the
care managers through weekly telephone contact. During these
contacts, the care managers presented new patients and follow
up contacts. Based on the participants’ responses to the
questionnaire, the psychiatrist could suggest changes either
through the care manager or by direct contact with the clinician.
Clinicians were also able to contact the psychiatrists for informal
telephone advice.
Depending on experience, the care managers received train-
ing for 4-8 hours. The psychiatrists received one hour’s training.
Intervention clinicians took part in a one to two hour
educational programme that addressed the diagnosis of depres-
sion, assessment of suicidal thoughts, response to management
on the basis of responses to the questionnaire, and modification
of management to achieve remission. Staff in the intervention
practices received a 45 minute course on the intervention, and
both they and the clinicians were instructed on procedures for
enrolling patients.
Clinicians in the practices allocated to usual care took part in
a 45-60 minute programme on diagnosis of depression and
assessment of suicidal thoughts. Both they and their staff were
instructed on procedures for enrolling patients.
With financial support from our project, the five organisa-
tions developed the autonomy to implement the model and to
maintain it through follow up with the practices. The
organisations identified care managers and psychiatrists, who
were trained by employees of the organisations. These
employees gradually assumed responsibility for training.
Blinding and data collection
The evaluation centre assessed the clinical course of the patients
through interviews by telephone at baseline and at three and six
months. Interviewers were blind to study group assignment, fol-
lowed computer aided scripts, and had no knowledge of the pur-
pose of the study or of the intervention. The Hopkins symptom
check list-20 was used to assess the severity of depression. The
interviewers also asked about current drugs, recent care, and sat-
isfaction with care. Interviews lasted about 30 minutes.
Statistical analysis
We use means (standard deviations) for continuous variables and
percentages for categorical variables. Our primary outcomes
included depressive symptoms (scores on the Hopkins symptom
check list-20), response to treatment (50% or more reduction in
depression score from baseline), and remission ( < 0.5 depres-
sion score). The process of treatment was analysed for the
number of patient visits to primary care for depression, the
number of follow up telephone contacts, continued use of
antidepressants, and use of psychological counselling during the
past three months.
Baseline (n=181)
3 month (n=152); no interview (n=29)
6 month (n=146); no interview (n=35)
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We used linear mixed effects regression models, including
both fixed and random effects, to analyse the effect of the inter-
vention on continuous outcomes. We analysed the effect of the
intervention on binary outcomes with generalised linear mixed
effect models with a logit link. The random effects portion of
these models provides the structure needed to account for clus-
tering or potential lack of independence that may exist between
observations for the same practice.16 We fitted the mixed effects
using SAS Proc mixed and Proc nlmixed. Both progams use all
data to yield unbiased estimates of variables for mixed effect
models when outcomes are missing at random.17
We fit a random intercept model that included the fixed
effects of depression severity at baseline, intervention, and time.
We also fit models of a two way interaction (intervention by time)
for both the continuous and binary outcomes. Further, we tested
a three way interaction among intervention, time, and baseline
depression scores by testing intervention by time interaction
effect within each stratum defined by baseline scores of more
than two.
Our sample size calculation is based on a baseline depression
score of 1.5, a two tailed t test, and a between group clinically
meaningful difference of 0.15 (SD 0.50) in depression scores at
follow up. Adjusting for potential design effects, we determined
that we needed to recruit 60 practices (30 in each group).18 We
analysed our data on an intention to treat basis. Using methodol-
ogy to adjust for patient clustering within practice and a range of
practice intraclass correlation coefficients based on prior results,
we found that for a  of 0.2, an  of 0.05, and allowing for 15%
dropouts, we required 400 patients.19 20
Results
The characteristics of the practices and patients were well
balanced (tables 1 and 2). The mean depression score on the
Hopkins symptom checklist-20 for the total sample was 2.01,
which is consistent with moderate to severe symptoms.
According to the mental disorders patient health question-
naire,21 47% of usual care patients and 51% of intervention
patients (P = 0.42) had generalised anxiety, panic disorder, or
both.
Table 3 describes the process of care. Compared with the
usual care clinicians the intervention clinicians more often asked
patients about suicidal thoughts, offered educational materials,
and assisted in setting self management goals. Intervention
patients also received more follow up contact by visits or
telephone and were significantly more likely at both three and
six months to report receiving good or excellent care. We found
no differences between the groups for frequency with which cli-
nicians presented patients with treatment options or elicited
their preferences. The patterns of management (drugs alone,
counselling alone, or both) did not differ significantly. No
adverse events were reported.
Table 1 Characteristics of practices randomised to manage patients with
depression using evidence based model or usual care. Values are numbers
(percentages) unless stated otherwise
Characteristic Intervention practices (n=32)
Usual care practices
(n=28)
Mean (SD) No of clinicians 3.8 (3.4) 3.7 (2.7)
Mean (SD) No of km from
organisation central office
33.5 (31.7) 33.9 (29.1)
On-site mental health care 7 ( 22) 8 ( 29)
Specialty:
Family practice 21 (66) 19 ( 68)
Internal medicine 11 (34) 9 ( 32)
Location:
Suburban or rural 26 ( 81) 23 (82)
Urban 7 (22) 5 (18)
Ownership:
Healthcare organisation 17 (53) 20 (71)
Affiliated to, but not owned
by, organisation
15 (47) 8 (29)
Table 2 Baseline characteristics of patients being managed for depression
with evidence based model or usual care. Values are numbers (percentages)
unless stated otherwise
Characteristic Intervention group (n=224) Usual care group (n=181)
Women 83.5 76.2
Mean (SD) age (years) 41.8 (14.1) 42.2 (15.3)
Mean (SD) education 13.3 (2.4) 13.2 (2.2)
Ethnic minority 36 (16) 32 (18)
Married 127 (57) 97 (54)
Lives with others 193 (86) 162 (90)
Income above poverty level 172 (77) 41 (74)
Paid employment 135 (60) 114 (63)
Mean (SD) severity of
depression*
2.03 (0.65) 1.98 (0.65)
Major depression 176 (79) 142 (79)
Major depression and
dysthymia
44 (20) 34 (19)
Dysthymia 4 (2) 5 (3)
Generalised anxiety disorder 93 (42) 72 (40)
Panic disorder 51 (23) 32 (18)
*20 items (Hopkins symptom checklist-20) from Hopkins symptom checklist-90.
Table 3 Process of care for patients being managed for depression with
evidence based model or usual care. Values are percentages (numbers/total
numbers)
Variable Intervention group Usual care group P value
Actions at index visit:
Asked about suicidal
thoughts
88 (190/217) 69 (120/174) <.0001
Presented treatment
options
69 (153/223) 68 (121/179) 0.83
Asked about treatment
preference
55 (120/220) 54 (94/175) 0.87
Offered educational
materials
71 (156/221) 40 (70/176) <.0001
Assisted in setting self
management goals
31 (68/220) 19 (34/179) 0.007
Taking antidepressants:
Baseline 92 (204/223) 88 (159/181) 0.23
3 months 88 (161/183) 85 (128/150) 0.48
6 months 79 (140/177) 81 (116/144) 0.74
Receiving counselling
(past three months):
Baseline 16 (35/223) 15 (26/179) 0.75
0-3 months 26 (47/182) 23 (34/149) 0.53
4-6 months 26 (46/177) 24 (35/146) 0.68
≥1 follow up visits for
depression:
0-3 months 85 (156/183) 71 (107/150) 0.002
4-6 months 65 (114/175) 51 (74/145) 0.01
≥1 follow up telephone
calls for depression
0-3 months 64 (116/181) 8 (12/148) <0.0001
4-6 months 59 (104/177) 3 (5/146) <0.0001
Patient rating of care as
good to excellent:
3 months 91 (163/179) 81 (119/147) 0.008
6 months 90 (160/177) 75 (110/146) 0.0003
Denominators vary owing to missing data.
Primary care
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Table 4 presents depression scores, response, and remission
based on intention to treat. Intervention patients had better out-
comes on all measures at both follow up intervals. Although
mean depression scores declined among patients in both
groups, the decline was significantly greater in intervention
patients: the intervention effect size on the Hopkins symptom
checklist-20 was 0.23 at three months and 0.29 at six months.
Log books completed by the care managers indicated that a
mean of 20 minutes was expended for each telephone call,
including record keeping. The psychiatrists had infrequent con-
tact with the clinicians ( < 5% of patients). The clinicians reported
negligible time demands from the model aside from administra-
tive duties such as obtaining consent.
Now that our trial is complete, the leaders of the
organisations have sustained the model and disseminated it fur-
ther with local resources. As of March 31, 2004 an additional 139
practices have been supported to implement the model.
Discussion
Enhanced management of depression can improve outcomes
for patients when implemented through quality improvement
resources increasingly available to community practices.
Depressed patients in our intervention practices reported
significantly milder symptoms of depression and had higher
response and remission rates at follow up than patients in the
usual care practices. The effect sizes are comparable to those of
other trials on depression in primary care.22
We identified elements that possibly influence clinical
outcomes. The intervention patients had more telephone
contacts and more visits. Intervention patients reported that the
clinicians were more likely to assess suicide risk, offer educational
materials, and assist with self management goals. Counselling
and adherence to antidepressants were similar between the
groups, suggesting that specific but modest support for patients
result in better outcomes for depression and higher patient rat-
ings for quality of care.
Although clinical outcomes were enhanced, these effects
were modest. At least four features of our study may help to
explain this. Firstly, rather than identifying potentially ambivalent
patients through screening, all patients were identified during
routine care by the clinicians, had accepted the diagnosis of
depression, and had agreed to be managed with drugs or by
counselling. Secondly, the usual care clinicians performed well
on process and outcome measures compared with those in other
trials,22 23 creating a high standard of comparison. Thirdly, there
was potential for attenuation of the intervention tasks compared
with their direct implementation by researchers using a strict
protocol.24 Finally, our intervention was modest compared with
other recent large trials. Unlike our trial, IMPACT (improving
mood-promoting access to collaborative treatment), PIC
(partners in care), and PROSPECT (prevention of suicide in pri-
mary care elderly: collaborative trial) offered increased access to
mental health services at no or reduced cost.20 23 25
Given these design features and dependence of the interven-
tion on training manuals and existing quality improvement
resources rather than research protocols and transient resources,
the superior outcomes compared with usual care are noteworthy.
We acknowledge that remission rates at six months indicate that
most patients had at least partial symptoms. These patients con-
tinued to receive support and may have improved further, as
found in longer term studies.20 23 26 Evaluation interviews in our
study were completed by six months after patient enrolment in
keeping with the commitment to provide the model to usual care
practices in that time.
We suggest that by recruiting 60 practices in diverse
locations, our trial extends the generalisability of earlier findings
on efficacy of telephone support and primary care specialty
cooperation beyond special settings. Many of these earlier stud-
ies took place in health maintenance organisations, academic
sites, or veterans administration practices.27–31 Our trial adds to
this knowledge by showing that modest resources delivered
through established programmes can approach outcomes
achieved by more research intense, resource rich interventions.
These findings take on added importance in light of the negative
result from the Hampshire depression project in which the
intervention was based on clinician education but did not
include telephone support or psychiatry for patients.32 In
addition, some US government bodies have called for more
intensive monitoring of patients prescribed antidepressants.33
Our model provides this, including assessment of suicidal
thoughts.
The generalisability of our findings to primary care are con-
strained because the practices had access to established quality
improvement programmes and care management staff,
resources which are becoming more widely, but not yet
universally, available. Attention to quality improvement is grow-
ing.8 9 34 Primary care trusts in the United Kingdom may be able
to assume this function, and in some countries professional soci-
eties and regional health authorities could play a part.
Our study shows the feasibility of doing rigorous research in
community practice settings relying on established resources to
Table 4 Clinical outcomes for patients being managed for depression with evidence based model or usual care. Values are percentages (number of
patients/total number) unless stated otherwise
Outcomes Intervention patients Usual care patients
Between group difference or odds ratio
(95% CI)* P value
Mean (SD) severity of depression†:
Baseline 2.04 (0.66) 1.98 (0.65) 0.15 (−0.03 to 0.33) 0.105
3 months 1.16 (0.80) 1.29 (0.76) −0.16 (−0.32 to −0.002) 0.048
6 months 0.97 (0.80) 1.09 (0.74) −0.20 (−0.39 to −0.014) 0.036
Response‡:
3 months 53.0 (97/183) 34.2 (52/152) 2.2 (1.4 to 3.4) 0.001
6 months 59.9 (106/177) 46.6 (68/146) 1.7 (1.1 to 2.7) 0.021
Remission§:
3 months 26.2 (48/183) 16.5 (25/152) 2.1 (1.2 to 3.7) 0.018
6 months 37.3 (66/177) 26.7 (39/146) 1.9 (1.2 to 3.3) 0.014
*Adjusted for variability in practices. All patients have at least 0.5 score on Hopkins symptom checklist-20 at baseline.
†Scores on Hopkins symptom checklist-20.
‡At least 50% decrease in depression score from baseline.
§Score of <0.5 on Hopkins symptom checklist-20.
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deliver the intervention rather than on transient research teams.
Using this approach would enable future research in primary
care to explore sustainability and dissemination of interventions.
In addition, materials created to support these interventions
could be more readily modified for application outside the
research setting.
Our model for depression produced significantly better out-
comes and more favourable patient responses on quality of care
than usual care. The model requires only modest changes from
practices and creates a framework to study long term sustainabil-
ity and dissemination of evidence based care.
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What is already known on this topic
Trials have shown improved outcomes for depression in
primary care patients using models for the management of
chronic illness
These models involve more systematic follow up and
monitoring, patient telephone support, and cooperation
between primary care and psychiatry
Implementation of these models has usually depended on
research teams and has not been sustainable when research
support ends
What this study adds
Evidence based models of depression management can be
implemented in primary care with support from existing
quality improvement resources
These models can improve outcomes for depression
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